These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 25672442

  • 1. Baicalein suppresses 17-β-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway.
    Shang D, Li Z, Zhu Z, Chen H, Zhao L, Wang X, Chen Y.
    Oncol Rep; 2015 Apr; 33(4):2077-85. PubMed ID: 25672442
    [Abstract] [Full Text] [Related]

  • 2. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y, Li Z, He Y, Shang D, Pan J, Wang H, Chen H, Zhu Z, Wan L, Wang X.
    Toxicol Appl Pharmacol; 2014 Mar 01; 275(2):176-81. PubMed ID: 24440569
    [Abstract] [Full Text] [Related]

  • 3. Baicalein has protective effects on the 17β-estradiol-induced transformation of breast epithelial cells.
    Chen Y, Wang J, Hong DY, Chen L, Zhang YY, Xu YN, Pan D, Fu LY, Tao L, Luo H, Shen XC.
    Oncotarget; 2017 Feb 07; 8(6):10470-10484. PubMed ID: 28060756
    [Abstract] [Full Text] [Related]

  • 4. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.
    Madeo A, Maggiolini M.
    Cancer Res; 2010 Jul 15; 70(14):6036-46. PubMed ID: 20551055
    [Abstract] [Full Text] [Related]

  • 5. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
    Zhou K, Sun P, Zhang Y, You X, Li P, Wang T.
    Steroids; 2016 Jul 15; 111():113-120. PubMed ID: 26850467
    [Abstract] [Full Text] [Related]

  • 6. Baicalein, unlike 4-hydroxytamoxifen but similar to G15, suppresses 17β-estradiol-induced cell invasion, and matrix metalloproteinase-9 expression and activation in MCF-7 human breast cancer cells.
    Chen Y, Hong DY, Wang J, Ling-Hu J, Zhang YY, Pan D, Xu YN, Tao L, Luo H, Shen XC.
    Oncol Lett; 2017 Aug 15; 14(2):1823-1830. PubMed ID: 28789417
    [Abstract] [Full Text] [Related]

  • 7. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
    Tsai CL, Wu HM, Lin CY, Lin YJ, Chao A, Wang TH, Hsueh S, Lai CH, Wang HS.
    PLoS One; 2013 Aug 15; 8(9):e72999. PubMed ID: 24039841
    [Abstract] [Full Text] [Related]

  • 8. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M.
    Cancer Res; 2007 Feb 15; 67(4):1859-66. PubMed ID: 17308128
    [Abstract] [Full Text] [Related]

  • 9. Regulation of HRG-β1-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression.
    Ruan SQ, Wang SW, Wang ZH, Zhang SZ.
    Mol Med Rep; 2012 Jul 15; 6(1):131-8. PubMed ID: 22576740
    [Abstract] [Full Text] [Related]

  • 10. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ, Quinn JA, Bland KI, Frackelton AR.
    Mol Endocrinol; 2000 Oct 15; 14(10):1649-60. PubMed ID: 11043579
    [Abstract] [Full Text] [Related]

  • 11. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
    Kleuser B, Malek D, Gust R, Pertz HH, Potteck H.
    Mol Pharmacol; 2008 Dec 15; 74(6):1533-43. PubMed ID: 18768737
    [Abstract] [Full Text] [Related]

  • 12. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.
    Mo Z, Liu M, Yang F, Luo H, Li Z, Tu G, Yang G.
    Breast Cancer Res; 2013 Nov 29; 15(6):R114. PubMed ID: 24289103
    [Abstract] [Full Text] [Related]

  • 13. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
    Schmidt-Wolf R, Zissel G.
    Anticancer Res; 2020 Jun 29; 40(6):3097-3108. PubMed ID: 32487604
    [Abstract] [Full Text] [Related]

  • 14. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ, Quinn JA, Frackelton AR, Bland KI.
    Mol Endocrinol; 2002 Jan 29; 16(1):70-84. PubMed ID: 11773440
    [Abstract] [Full Text] [Related]

  • 15. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A, Romeo E, De Marco P, De Francesco EM, Abonante S, Maggiolini M.
    Breast Cancer Res Treat; 2012 Jun 29; 133(3):1025-35. PubMed ID: 22147081
    [Abstract] [Full Text] [Related]

  • 16. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway.
    He YY, Cai B, Yang YX, Liu XL, Wan XP.
    Cancer Sci; 2009 Jun 29; 100(6):1051-61. PubMed ID: 19432902
    [Abstract] [Full Text] [Related]

  • 17. 4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells.
    Li Y, Chen Y, Zhu ZX, Liu XH, Yang L, Wan L, Lei TW, Wang XD.
    Toxicology; 2013 Jul 05; 309():61-5. PubMed ID: 23624423
    [Abstract] [Full Text] [Related]

  • 18. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells.
    Wang L, Ling Y, Chen Y, Li CL, Feng F, You QD, Lu N, Guo QL.
    Cancer Lett; 2010 Nov 01; 297(1):42-8. PubMed ID: 20580866
    [Abstract] [Full Text] [Related]

  • 19. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
    Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S.
    J Biol Chem; 2004 Jun 25; 279(26):27008-16. PubMed ID: 15090535
    [Abstract] [Full Text] [Related]

  • 20. Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3-MAPK/ERK pathway.
    Ruan SQ, Wang ZH, Wang SW, Fu ZX, Xu KL, Li DB, Zhang SZ.
    Biochem Biophys Res Commun; 2012 Apr 06; 420(2):385-90. PubMed ID: 22425775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.